The Plasma DIA-Based Quantitative Proteomics Reveals the Pathogenic Pathways and New Biomarkers in Cervical Cancer and High Grade Squamous Intraepithelial Lesion.
Sai HanJunhua ZhangYu SunLu LiuLingyu GuoChunru ZhaoJiaxin ZhangQiuhong QianBaoxia CuiYouzhong ZhangPublished in: Journal of clinical medicine (2022)
DIA-ELSIA combined analysis screened and validated two previously unexplored but potentially useful biomarkers for early diagnosis of HSIL and cervical cancer, as well as possible new pathogenic pathways and therapeutic targets.